ArticleCureus2026
Occult Insulinoma: A 19-Year Diagnostic Delay in a Patient With Recurrent Hypoglycemia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recurrent hypoglycemia may present a diagnostic challenge when initial biochemical and imaging studies are inconclusive. We report the case of a 47-year-old man who presented with a 19-year history of recurrent hypoglycemic episodes characterized by diaphoresis, tremor, palpitations, intense hunger, dizziness, blurred vision, and impaired concentration. Initial evaluation documented hypoglycemia; however, insulin and C-peptide concentrations did not meet the diagnostic criteria for endogenous hyperinsulinism, and abdominal computed tomography (CT) failed to identify a pancreatic lesion. Persistent symptoms prompted reevaluation 19 years later, revealing endogenous hyperinsulinemic hypoglycemia and a 16-mm pancreatic body lesion on contrast-enhanced magnetic resonance imaging (MRI). The patient underwent distal pancreatectomy, and histopathological examination confirmed a well-differentiated pancreatic neuroendocrine tumor consistent with insulinoma. Following surgery, hypoglycemic symptoms completely resolved. This case highlights how insulinoma may remain clinically occult for prolonged periods when initial biochemical and imaging findings are nondiagnostic. Persistent or recurrent hypoglycemic symptoms should prompt continued clinical suspicion and periodic reassessment, even after inconclusive investigations, as repeat biochemical evaluation and evolving localization strategies may facilitate definitive diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.